Mitochondria and cardiac hypertrophy

47Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Cardiac tissue responds to long-term hemodynamic load through initiation of a hypertrophic remodeling program. Importantly, if not counteracted this response will eventually lead to organ failure. Cardiac hypertrophic adaptations are complex, and involve multiple cellular events and the mechanisms underlying the development of cardiac hypertrophy are not well understood. Mitochondrial dysfunction has been indicated as a potential and important player in the development of cardiac hypertrophy. Additionally, substantial evidence shows that a significant portion of mitochondrial processes, necessary for normal cardiomyocyte physiology, are impacted by these hypertrophic changes. In this chapter, we will present and discuss the adaptations and changes in the mitochondrial electron transport system, mitochondrial metabolism, mitochondrial biogenesis, oxidative stress, the opening of the mitochondrial permeability transition pore following hypertrophic stimuli, as well as, review the various drugs (targeting mitochondria) that can be used in treatment of cardiac hypertrophy.

Cite

CITATION STYLE

APA

Facundo, H. di T. F., Brainard, R. E., Caldas, F. R. de L., & Lucas, A. M. B. (2017). Mitochondria and cardiac hypertrophy. In Advances in Experimental Medicine and Biology (Vol. 982, pp. 203–226). Springer New York LLC. https://doi.org/10.1007/978-3-319-55330-6_11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free